Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
27.78
16.01
57.63%
Share Warrants & Outstandings
Total Reserve
19.05
286.19
-267.14
-93.34%
Shareholder's Funds
62.84
313.97
-251.13
-79.99%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
160.51
-157.40
-98.06%
Secured Loans
1.64
0.00
1.64
0.00%
Unsecured Loans
1.48
160.51
-159.03
-99.08%
Deferred Tax Assets / Liabilities
3.41
13.98
-10.57
-75.61%
Other Long Term Liabilities
0.13
9.66
-9.53
-98.65%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
19.95
-19.95
-100.00%
Total Non-Current Liabilities
6.65
204.10
-197.45
-96.74%
Current Liabilities
Trade Payables
9.22
164.83
-155.61
-94.41%
Other Current Liabilities
4.27
87.70
-83.43
-95.13%
Short Term Borrowings
1.06
67.94
-66.88
-98.44%
Short Term Provisions
2.74
30.93
-28.19
-91.14%
Total Current Liabilities
17.28
351.40
-334.12
-95.08%
Total Liabilities
86.77
869.47
-782.70
-90.02%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
835.74
-792.32
-94.80%
Less: Accumulated Depreciation
24.03
487.67
-463.64
-95.07%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
348.06
-328.66
-94.43%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
87.41
-85.46
-97.77%
Intangible assets under development
0.00
31.64
-31.64
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
68.50
-68.50
-100.00%
Long Term Loans & Advances
0.00
39.14
-39.14
-100.00%
Other Non Current Assets
0.00
1.00
-1.00
-100.00%
Total Non-Current Assets
21.34
575.74
-554.40
-96.29%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
152.10
-142.15
-93.46%
Sundry Debtors
8.77
20.85
-12.08
-57.94%
Cash and Bank
12.12
62.16
-50.04
-80.50%
Other Current Assets
20.17
3.22
16.95
526.40%
Short Term Loans and Advances
14.42
55.40
-40.98
-73.97%
Total Current Assets
65.43
293.73
-228.30
-77.72%
Net Current Assets (Including Current Investments)
48.14
-57.67
105.81
183.47%
Total Current Assets Excluding Current Investments
65.43
293.73
-228.30
-77.72%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
869.47
-782.70
-90.02%
Contingent Liabilities
1.40
367.09
-365.69
-99.62%
Total Debt
4.18
228.45
-224.27
-98.17%
Book Value per share (adjusted)
1.44
47.72
-46.28
-96.98%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024






